Politics

VC isn't VC anymore — understanding the rise of Cancer Capital

Anil Dash, writing from experience as a startup CEO and board member, argues that a handful of mega-funds have transformed venture capital from a risk-bearing minority of the capital markets into an unaccountable oligarchic force he calls "Cancer Capital." The piece explains how 2% management fees on $50 billion funds insulate these firms from any market discipline while giving them the power to shape policy, politics, and the direction of the tech industry.

Essay · Venture Capital · Tech Industry · Power · Economics